Pioneer Surgical Technology has announced the first clinical use of its nanOss Bioactive 3D, which is part of its biologic bone graft product line nanOss Bioactive, according to a company news release.
The new device uses proprietary nanocrystalline hydroxyapatite and collagen-based biopolymer to promote bone growth in the posterolateral spine. The company now offers a full line of synthetic bone grafts and human tissue products for spine surgery.
Related Articles on Spine Devices:
26 Spine Devices Receive FDA 510(k) Clearance in December
5 Spine-Driven Device Company Financial Reports
14 Spine Device Company Executive Moves
Related Articles on Spine Devices:
26 Spine Devices Receive FDA 510(k) Clearance in December
5 Spine-Driven Device Company Financial Reports
14 Spine Device Company Executive Moves